Prostate Cancer Awareness Month Interview Series
Hear from expert urologist Dr. Rami Yaacoub on how COVID-19 has affected his practice and how they’re adapting with telehealth.
Internationally renowned urologist Dr. E. David Crawford explains how he uses the Select mdx for Prostate Cancer test and what a positive result can mean for diagnosis and treatment.
Select mdx for Prostate Cancer
About Select mdx for prostate cancer
Jack A Schalken, PhD, and E. David Crawford, MD, discuss recent advances in non invasive liquid biopsies for prostate cancer, and the impact of Select mdx.
AUA 2022 Best Poster: Select mdx and Multiparametric Magnetic Resonance Imaging Improve the Diagnostic Workup for the Detection of Prostate Cancer in Biopsy-naive Men
Confirm mdx for Prostate Cancer
About Confirm mdx for Prostate Cancer
How Confirm mdx works
Wim Van Criekinge, PhD, Professor of Computational Genomics and Bioinformatics at Ghent University in Ghent, Belgium, and Chief Scientific Officer for mdxhealth, discusses Confirm mdx, a test for prostate cancer that uses tissue from a negative biopsy.
PyschArmor Institute Biomarker Test Education Series
Navigating the Prostate Cancer Journey (for Veterans and Their Caregivers). The PsychArmor Institute partnered with Dr. Leonard Gomella to explain why biomarker tests, such as Select mdx and Confirm mdx, are important to ask about while being cared for at the VA.
Demystifying Genomic Testing (for Urologists). The PsychArmor Institute partnered with Dr. Leonard Gomella to explain how VA urologists can use biomarker tests, such as Select mdx and Confirm mdx, to improve prostate cancer outcomes for Veterans.
New Genomic Solutions (for Pathologists). The PsychArmor Institute partnered with Dr. Kirk Wojno to explain how VA pathologists can use ConfirmMDx results to provide more insight on a patient’s risk for aggressive prostate cancer.